For researchers and clinicians, the approval reinforces the idea that these therapies could play a broader role in tackling metabolic diseases
Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al
GLPRO-1 * PDV = priporoen dnevni vnos | REBERSA je blagovna znamka podjetja Sabinsa Night GLPRO-1 * PDV = priporoen dnevni vnos | REBERSA je blagovna znamka podjetja Sabinsa Zakaj je neodvisno testiranje kljunega pomena Pri Natures Finest verjamemo, da se dobro poutje zane z zaupanjem
Pharmacological evaluation of a beta-hydroxyphosphonate analogue of l-carnitine in obese Zucker fa/fa rats